Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Fakhar Siddiqui, MD, MBA
Merck & Co., Inc.
Disclosure(s): Merck & Co Inc.: Stocks/Bonds (Public Company)
Poster(s):
(P-1155) Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam and Comparators Against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa Isolated from Patients with Invasive Respiratory Infections: SMART United States, 2021-2023
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
